996 related articles for article (PubMed ID: 24314824)
21. Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer.
Gajria D; Gonzalez J; Feigin K; Patil S; Chen C; Theodoulou M; Drullinsky P; D'Andrea G; Lake D; Norton L; Hudis CA; Traina TA
Breast Cancer Res Treat; 2012 Jan; 131(1):111-6. PubMed ID: 21898114
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors for the feasibility of chemotherapy and the Geriatric Prognostic Index (GPI) as risk profile for mortality before chemotherapy in the elderly.
Aaldriks AA; Maartense E; Nortier HJ; van der Geest LG; le Cessie S; Tanis BC; Portielje JE; Ypma P; Giltay EJ
Acta Oncol; 2016 Jan; 55(1):15-23. PubMed ID: 26271800
[TBL] [Abstract][Full Text] [Related]
23. Immune senescence and cancer in elderly patients: results from an exploratory study.
Falci C; Gianesin K; Sergi G; Giunco S; De Ronch I; Valpione S; Soldà C; Fiduccia P; Lonardi S; Zanchetta M; Keppel S; Brunello A; Zafferri V; Manzato E; De Rossi A; Zagonel V
Exp Gerontol; 2013 Dec; 48(12):1436-42. PubMed ID: 24120567
[TBL] [Abstract][Full Text] [Related]
24. Moderate dose capecitabine in older patients with metastatic breast cancer: a standard option for first line treatment?
Kotsori AA; Noble JL; Ashley S; Johnston S; Smith IE
Breast; 2010 Oct; 19(5):377-81. PubMed ID: 20392643
[TBL] [Abstract][Full Text] [Related]
25. Single-agent capecitabine maintenance therapy after response to capecitabine-based combination chemotherapy in patients with metastatic breast cancer.
Huang H; Jiang Z; Wang T; Zhang S; Bian L; Cao Y; Wu S; Song S
Anticancer Drugs; 2012 Aug; 23(7):718-23. PubMed ID: 22739713
[TBL] [Abstract][Full Text] [Related]
26. Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer.
Rossi D; Alessandroni P; Catalano V; Giordani P; Fedeli SL; Fedeli A; Baldelli AM; Casadei V; Ceccolini M; Catalano G
Clin Breast Cancer; 2007 Dec; 7(11):857-60. PubMed ID: 18269775
[TBL] [Abstract][Full Text] [Related]
27. Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy.
Aaldriks AA; van der Geest LG; Giltay EJ; le Cessie S; Portielje JE; Tanis BC; Nortier JW; Maartense E
J Geriatr Oncol; 2013 Jul; 4(3):218-26. PubMed ID: 24070460
[TBL] [Abstract][Full Text] [Related]
28. Maintenance treatment with pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study.
Alba E; Ruiz-Borrego M; Margelí M; Rodríguez-Lescure A; Sánchez-Rovira P; Ruiz A; Mel-Lorenzo JR; Ramos-Vázquez M; Ribelles N; Calvo E; Casado A; Márquez A; Vicente D; García-Sáenz JA; Martín M
Breast Cancer Res Treat; 2010 Jul; 122(1):169-76. PubMed ID: 20361253
[TBL] [Abstract][Full Text] [Related]
29. Functional decline in older patients with cancer receiving first-line chemotherapy.
Hoppe S; Rainfray M; Fonck M; Hoppenreys L; Blanc JF; Ceccaldi J; Mertens C; Blanc-Bisson C; Imbert Y; Cany L; Vogt L; Dauba J; Houédé N; Bellera CA; Floquet A; Fabry MN; Ravaud A; Chakiba C; Mathoulin-Pélissier S; Soubeyran P
J Clin Oncol; 2013 Nov; 31(31):3877-82. PubMed ID: 24062399
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals.
Barthélémy P; Heitz D; Mathelin C; Polesi H; Asmane I; Litique V; Rob L; Bergerat JP; Kurtz JE
Crit Rev Oncol Hematol; 2011 Aug; 79(2):196-204. PubMed ID: 20655243
[TBL] [Abstract][Full Text] [Related]
31. Frailty status but not age predicts complications in elderly cancer patients: a follow-up study.
Ørum M; Gregersen M; Jensen K; Meldgaard P; Damsgaard EMS
Acta Oncol; 2018 Nov; 57(11):1458-1466. PubMed ID: 30280625
[TBL] [Abstract][Full Text] [Related]
32. Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women > or = 65 years of age.
Addeo R; Faiola V; Guarrasi R; Montella L; Vincenzi B; Capasso E; Cennamo G; Rotundo MS; Tagliaferri P; Caraglia M; Del Prete S
Cancer Chemother Pharmacol; 2008 Jul; 62(2):285-92. PubMed ID: 17922275
[TBL] [Abstract][Full Text] [Related]
33. Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer.
Chan A; Conte PF; Petruzelka L; Tubiana-Mathieu N; Ganju V; Llombart A; Espie M; Majois F; Gil MG; Vaissiere N; Villanova G
Anticancer Res; 2013 Jun; 33(6):2657-64. PubMed ID: 23749924
[TBL] [Abstract][Full Text] [Related]
34. Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes.
Jones A; O'Brien M; Sommer H; Nowara E; Welt A; Pienkowski T; Rolski J; Pham ML; Perraud K; Trillet-Lenoir V
Cancer Chemother Pharmacol; 2010 Mar; 65(4):755-63. PubMed ID: 19669644
[TBL] [Abstract][Full Text] [Related]
35. Physical function and quality of life in frail and/or elderly patients with metastatic colorectal cancer treated with capecitabine and bevacizumab: an exploratory analysis.
Ward P; Hecht JR; Wang HJ; Dichmann R; Liem AK; Chan D; Patel R; Hu EH; Tchekmedyian NS; Wainberg ZA; Naeim A
J Geriatr Oncol; 2014 Oct; 5(4):368-75. PubMed ID: 25002322
[TBL] [Abstract][Full Text] [Related]
36. Can older cancer patients tolerate chemotherapy? A prospective pilot study.
Chen H; Cantor A; Meyer J; Beth Corcoran M; Grendys E; Cavanaugh D; Antonek S; Camarata A; Haley W; Balducci L; Extermann M
Cancer; 2003 Feb; 97(4):1107-14. PubMed ID: 12569613
[TBL] [Abstract][Full Text] [Related]
37. The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal cancer: a randomized trial (GERICO).
Lund CM; Vistisen KK; Dehlendorff C; Rønholt F; Johansen JS; Nielsen DL
BMC Cancer; 2017 Jun; 17(1):448. PubMed ID: 28659138
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of single agent capecitabine in pretreated metastatic breast cancer patients from the French compassionate use program.
Pierga JY; Fumoleau P; Brewer Y; Zelek L; Martin D; Turpin FL; Goudier MJ; Gil-Delgado M; Baticle JL; Namer M; Chollet P; Sutherland W; Barats JC;
Breast Cancer Res Treat; 2004 Nov; 88(2):117-29. PubMed ID: 15564795
[TBL] [Abstract][Full Text] [Related]
39. Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.
Mlineritsch B; Schabel-Moser R; Andel J; Fridrik M; Moik M; Mayer P; Russ G; Rass C; Greil R;
Onkologie; 2009 Feb; 32(1-2):18-24. PubMed ID: 19209014
[TBL] [Abstract][Full Text] [Related]
40. Slow accrual of elderly patients with metastatic breast cancer in the Dutch multicentre OMEGA study.
Hamaker ME; Seynaeve C; Nortier JW; Wymenga M; Maartense E; Boven E; van Leeuwen-Stok AE; de Rooij SE; van Munster BC; Smorenburg CH
Breast; 2013 Aug; 22(4):556-9. PubMed ID: 23305962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
